Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 310 participants.
Also called NCT05340582
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 310 participants
- Registry
-
NCT05340582
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, Canada, Hong Kong SAR China, Ireland
- Registry status
- Recruiting
Technical summary
Registry record NCT05340582. Randomized; triple masking; primary purpose treatment. Start 2022-12-12 (actual); primary completion 2027-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants
- Condition
- Patent Ductus Arteriosus After Premature Birth
- Intervention (Drug)
- Acetaminophen Injection
- Intervention (Drug)
- Ibuprofen 20 mg/mL oral suspension or Ibuprofen lysine 10 mg/mL injection solution (Neoprofen)
- Intervention (Other)
- Sodium chloride 0.9% injection
- Lead sponsor
- Mount Sinai Hospital, Canada
- Collaborator
- Sunnybrook Health Sciences Centre
- Collaborator
- McMaster Children's Hospital
- Collaborator
- The Rotunda Hospital
- Collaborator
- John Hunter Hospital
- Collaborator
- Royal Alexandra Hospital
- Collaborator
- Centre de Recheche du Centre Hospitalier Université Laval
- Collaborator
- Royal North Shore Hospital
- Collaborator
- Prince of Wales Hospital, Shatin, Hong Kong
Record details
- Record id
cardio:ct-nct05340582- Content hash
c8bdf71f5ed12c3aaf6e5d657ec83dd6fb65277425cb3b86ed9b58bb9ba404cb